Please login to the form below
EC
This page shows the latest EC news and features for those working in and with pharma, biotech and healthcare.
Shire’s bleeding disorder drug approved in Europe
Veyvondi for patients with rare disease von Willebrand disease. The European Commission (EC) has given the green light to Shire’s haemostatic disorder treatment Veyvondi, which is now set to prevent
Latest news
-
MSD wins key EU approval for Keytruda, Alimta combo
The European Commission (EC) based its decision off data from the KEYNOTE-189 trial, which looked at the treatment in patients who were non-, low and high expressions of the
-
Eisai’s Lenvima wins European liver cancer indication
EC green-lights the RTK inhibitor as a first-line treatment. Japanese pharma group Eisai and partner Merck &Co have received a nod from the European Commission (EC) to market its
-
First migraine prevention drug to hit European market
The European Commission (EC) approved the novel treatment yesterday after it received a positive recommendation from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last
-
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
EC earlier this month.
-
Roche wins European approval for bleeding disorder treatment Hemlibra
The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab).
More from news
Approximately 15 fully matching, plus 258 partially matching documents found.
Latest Intelligence
-
Tackling a formidable foe
A year ago the company won EC approval for MAVENCLAD, a course of just 20 tablets that tames the body’s immune response system and can be taken on ten consecutive
-
The sound of silence puts the squeeze on generics and biosimilars
EFPIA issued a statement on its position, stating: “The SPC regime is part of the current EC review of incentives.
-
European CTR implementation advances ethical assessment of clinical trials
well as a clear process of selection of a Central ‘EC’ that will be dealing with a trial. ... who would deal with a selection of the appropriate EC, timelines and financial aspects.
-
Europe vs the US: New drug product approvals
pending approval by the European Commission (EC) in January 2017 (compared to no biosimilars gaining EU approval in 2015).
-
Real-world evidence: It’s all in the approach
the EC point out the uses of such data in supporting pharmacovigilance, comparative efficacy and pricing negotiations for new treatments.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
CureVac’s CEO appointed to EC High Level Group
Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough, market-creating innovation in the Horizon 2020 project as well
-
New EC health director general takes office
Prats Monné's appointment was part of a reshuffle of the Commission's senior management by president Jean-Claude Juncker and, in a statement, the EC said the changes were a
-
IMI appoints new chair of scientific committee
Portugal’s Maria Beatriz da Silva Lima to join EC’s collaborative research group. ... the EC and the industry to improve health innovation in Europe.
-
Jonathan Dickinson joins Ariad from BMS
He joins at an important time for Ariad in Europe as it prepares to launch its chronic myeloid leukaemia treatment Iclusig (ponatinib), pending approval from the European Commission (EC).
-
Tonio Borg nominated to replace John Dalli as EC Health Commissioner
Candidacy of the Maltese deputy prime minister and minister of foreign affairs accepted by Barroso
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Ensuring quality in medical translation when working ‘blind’
There is also often the need for a review by an Ethics Committee (EC), which can remove some errors, but can introduce spelling or grammar errors too. ... Any EC or client changes should be sent back to the original translators to be checked again.
-
Can rare diseases be a viable option for the pharma industry?
EU has enacted similar legislation, Regulation (EC) No 141/2000, in which pharmaceuticals developed to treat rare diseases are referred to as “orphan medicinal products”.
-
What we learnt from taking a mobile app through MHRA compliance
We launched an app that conforms to the EU Medical Device Directive 2007/47 EC for Rosemont Pharmaceuticals who are now registered as a Class 1 device manufacturer.
-
EC Meetings Company Ltd.
EC Meetings Company Ltd..
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Senior Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
-
Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Novartis forges AI alliance with Oxford University
- Editas CEO exits the CRISPR firm ahead of first clinical trial
- A dynamic and challenging environment – what it’s like starting a career in MedComms
- UniQure cleared to start Huntington gene therapy trial
- HSJ Partnership Awards 2019 shortlist announced
- Unlocking the potential of science and technology in the UK
- A Magical Future – A year on from the graduate scheme
PMHub
Genetic Digital
We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
